This Fund is Soft Closed and is not currently available to new investors

Biotechnology Fund

Equity investors in medical innovation

Launch Date31.10.2013
Base CurrencyUS$
DenominationsUS$ / GBP / EUR
DomicileDublin, Ireland
IndexNASDAQ Biotechnology
US$26.00
US$ Class I Dist
NAV per share 27.02.2020
£391.1mAUM

AUM 31.01.2020

Holdings
70.37% Active Share
As at 31.01.2020